Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature

Clin Genitourin Cancer. 2019 Oct;17(5):e903-e908. doi: 10.1016/j.clgc.2019.06.009. Epub 2019 Jul 8.
No abstract available

Keywords: Dialysis; Immunotherapy; Kidney cancer; Metastatic renal cell carcinoma; Nivolumab.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / administration & dosage*
  • Antineoplastic Agents, Immunological / adverse effects
  • Carcinoma, Renal Cell / drug therapy*
  • Feasibility Studies
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Nivolumab / administration & dosage*
  • Nivolumab / adverse effects
  • Renal Dialysis
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab